ArticleFrontiers in immunology2024

Dual immunotherapy alternating with anti-PD-1 antibody plus liposomal doxorubicin show good efficacy in prostate epithelioid hemangioendothelioma: a case report.

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.